- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Public Companies
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Environmental Agenda
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Christine E. Savage
Events 9 results
Speaking Engagement
September 20, 2021
Christine Savage to Co-Chair American Conference Institute’s 3rd Annual Conference on U.S.-China Trade Controls
Speaking Engagement
October 22, 2020
Christine Savage to Speak on American Conference Institute’s U.S.-China Trade Controls Virtual Conference
Webinar
June 30, 2020
Reshoring of Pharmaceuticals and Medical Devices
Webinar
April 22, 2020
COVID-19 Issues for Manufacturers
Webinar
February 27, 2020
CFIUS Reform: Impact on Foreign Investment in Pharmaceutical, Medical Device and Healthcare Companies
Speaking Engagement
February 19, 2020
Alexis Early, Christine Savage to Speak on ETA Spotlight Call About CFIUS Reform
Speaking Engagement
August 16, 2019
Christine Savage to Speak at Atlanta Compliance at Ethics Roundtable’s 12th Annual Best Practices Workshop
Speaking Engagement
April 24, 2019
Christine Savage to Co-Chair ACI’s 5th Annual National Conference on CFIUS & Team Telecom
Conference
June 15, 2016
2016 Compliance Summit